Abstract:The biosynthesis of antifungal lipopeptides iturin and fengycin has attracted broad interest; however, there is a bottleneck in its low yield in wild strains. Because the key metabolic mechanisms in the lipopeptides synthesis pathway remain unclear, genetic engineering approaches are all ending up with a single or a few gene modifications. The aim of this study is to develop a systematic engineering approach to improve the antifungal activity and biosynthesis of iturin and fengycin in Bacillus amyloliquefaciens. First, blocking the carbon overflow metabolic pathway to increase precursor supply of the branched-chain amino acids by knockout of bdh, disrupting sporulation to extend the stage for producing antifungal lipopeptides by deletion of kinA, blocking of siderophore synthesis to enhance the availability of amino acids and fatty acids by deletion of dhbF, and increasing Spo0A∼P by deletion of rapA, could improve the antifungal activity by 24%, 10%, 13% and 18%, respectively. Second, the double knockout strain ΔbdhΔkinA, triple knockout strain ΔbdhΔkinAΔdhbF and quadruple knockout strain ΔkinAΔbdhΔdhbFΔrapA could improve the antifungal activity by 38%, 44% and 53%, respectively. Finally, overexpression of sfp in ΔkinAΔbdhΔdhbFΔrapA further increased the antifungal activity by 65%. After purifying iturin and fengycin as standards for quantitative analysis of lipopeptides, we found the iturin titer was 17.0 mg/L in the final engineered strain, which was 3.2-fold of the original strain. After fermentation optimization, the titer of iturin and fengycin reached 31.1 mg/L and 175.3 mg/L in flask, and 123.5 mg/L and 1200.8 mg/L in bioreactor. Compared to the original strain, the iturin and fengycin titer in bioreactor increased by 22.8-fold and 15.9-fold in the final engineered strain, respectively. This study may pave the way for the commercial production of green antifungal lipopeptides, and is also favorable for understanding the regulatory and biosynthetic mechanism of iturin and fengycin.

Construction of Lipopeptide Mono-Producing Bacillus Strains and Comparison of Their Antimicrobial Activity

Clone of Plipastatin Biosynthetic Gene Cluster by Transformation-Associated Recombination Technique and High Efficient Expression in Model Organism Bacillus Subtilis

Plipastatin and Surfactin Coproduction by Bacillus Subtilis Pb2-L and Their Effects on Microorganisms

A comprehensive genomic and growth proteomic analysis of antitumor lipopeptide bacillomycin Lb biosynthesis in Bacillus amyloliquefaciens X030

Cloning, Sequencing, and Characterization of the Genetic Region Relevant to Biosynthesis of the Lipopeptides Iturin A and Surfactin in Bacillus subtilis

Enhanced Production of Antifungal Lipopeptide Iturin A by Bacillus Amyloliquefaciens LL3 Through Metabolic Engineering and Culture Conditions Optimization

Systemically Engineering Bacillus Amyloliquefaciens for Increasing Its Antifungal Activity and Green Antifungal Lipopeptides Production

The Efficient Synthesis Strategy of Bacillomycin D in Bacillus Amyloliquefaciens Fmbj

Mining New Plipastatins and Increasing the Total Yield Using CRISPR/Cas9 in Genome-Modified Bacillus Subtilis 1A751

An Integrated Pipeline and Overexpression of a Novel Efflux Transporter, YoeA, Significantly Increases Plipastatin Production in Bacillus subtilis

Co-production of Multiple Antimicrobial Compounds by Bacillus Amyloliquefaciens WY047, a Strain with Broad-Spectrum Activity

CodY, ComA, DegU and Spo0A Controlling Lipopeptides Biosynthesis in Bacillus Amyloliquefaciens Fmbj.

Screening a surfactin and iturin A producing strain and characterization of its lipopeptide products

Effect of translocation of NRPS thioesterase domain of Bacillomycin D synthase system on the synthesis of lipopeptides

Exogenous Addition of Alkanoic Acids Enhanced Production of Antifungal Lipopeptides in Bacillus Amyloliquefaciens Pc3

Isolation and characterization of a new cyclic lipopeptide surfactin from a marine-derived Bacillus velezensis SH-B74

Antifungal Effects of Lipopeptide Produced by Bacillus Amyloliquefaciens BH072

Production and Identification of Antifungal Compounds Produced by Bacillus subtilis B579

Genome Shuffling of Bacillus Amyloliquefaciens for Improving Antimicrobial Lipopeptide Production and an Analysis of Relative Gene Expression Using FQ RT-PCR

CodY, ComA, DegU and Spo0A Controlling Lipopeptides Biosynthesis in Bacillus Amyloliquefaciens Fmbj

The Bacillus Cereus Group is an Excellent Reservoir of Novel Lanthipeptides